• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Inspections, Compliance, Enforcement, and Criminal Investigations

  • Print
  • Share
  • E-mail

2009 Warning Letters

Recently Posted | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996

Warning Letters issued in 2009

 

* Not issued: A close-out letter may issue when, based on FDA’s evaluation, the firm has taken corrective action to address the violations contained in the Warning Letter. This procedure applies to Warning Letters issued on or after September 1, 2009.

* N/A: Not applicable, the Warning Letter was issued prior to September 1, 2009.

Read more about warning and close-out letters

 
-
Letter Issue Date Company Name Issuing Office Subject Close Out Date
February 02, 2009 Medical & Clinical Consortium Inc [ARCHIVED] Los Angeles District Office CGMP/QSR/Medical Devices/Adulterated N/A *
February 02, 2009 Chappel, Christopher, MD [ARCHIVED] Center for Drug Evaluation and Research Clinical Investigator N/A *
January 30, 2009 Acker, Randy J. [ARCHIVED] Minneapolis District Office Illegal Drug Residue N/A *
January 30, 2009 Lodi Veterinary Hospital, S.C. [ARCHIVED] Minneapolis District Office Illegal Drug Residue N/A *
January 30, 2009 Acker, Dennis L. [ARCHIVED] Minneapolis District Office Illegal Drug Residue N/A *
January 29, 2009 Degrave, Dale and Peggy [ARCHIVED] Minneapolis District Office Illegal Drug Residue N/A *
January 29, 2009 Prime Enterprises, Inc [ARCHIVED] Florida District Office CGMP for Finished Pharmaceuticals/Deviations/Adulterated N/A *
January 28, 2009 Cyclotron Center of NE Florida [ARCHIVED] Florida District Office Deviation/Adulterated N/A *
January 27, 2009 D & D Hawkins [ARCHIVED] Minneapolis District Office Illegal Drug Residue N/A *
January 27, 2009 Amedica Corporation [ARCHIVED] Center for Devices and Radiological Health Premarket Approval/Adulterated N/A *
January 26, 2009 Cannon Fish Company [ARCHIVED] Seattle District Office Seafood HACCP/Adulterated N/A *
January 26, 2009 First Season, Inc [ARCHIVED] Chicago District Office Seafood HACCP/Adulterated N/A *
January 23, 2009 Mainline Technology, Inc [ARCHIVED] Detroit District Office CGMP/QSR/Medical Devices/Adulterated N/A *
January 22, 2009 Sage Products Inc [ARCHIVED] Chicago District Office CGMP Manufacturer, Processsing, Packing, Holding Drugs/Devices/Adulterated N/A *
January 21, 2009 Stewart, Lynette D. M.D [ARCHIVED] Center for Drug Evaluation and Research Clinical Investigator N/A *
January 20, 2009 Nidek Medical Products Inc [ARCHIVED] New Orleans District Office CGMP/QSR/Medical Devices/Adulterated N/A *
January 20, 2009 Nidek Medical Products Inc [ARCHIVED] New Orleans District Office CGMP/QSR/Medical Devices/Adulterated N/A *
January 15, 2009 Haelan Products [ARCHIVED] Seattle District Office Promotional Claims False & Misleading/New Drug/Misbranded N/A *
January 15, 2009 Portland Shellfish Company, Inc. [ARCHIVED] New England District Office Seafood HACCP/CGMP for Foods/Adulterated N/A *
January 14, 2009 Brewer, George J. M.D. [ARCHIVED] Center for Drug Evaluation and Research Clinical Investigator N/A *



 

Contact FDA

ICECI Warning Letters

Division of Freedom of Information (HFI-35)

Food and Drug Administration

5600 Fishers Lane

Rockville, MD 20857
-